These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8396512

  • 1. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A, Ozand P, Sobki S, Sewairi W, Marx S.
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D.
    Weisman Y, Bab I, Gazit D, Spirer Z, Jaffe M, Hochberg Z.
    Am J Med; 1987 Nov; 83(5):984-90. PubMed ID: 2823606
    [Abstract] [Full Text] [Related]

  • 4. The role of the vitamin D receptor in regulating vitamin D metabolism: a study of vitamin D-dependent rickets, type II.
    Tiosano D, Weisman Y, Hochberg Z.
    J Clin Endocrinol Metab; 2001 May; 86(5):1908-12. PubMed ID: 11344183
    [Abstract] [Full Text] [Related]

  • 5. Oral calcium treatment in vitamin D-dependent rickets type II.
    Wong GW, Leung SS, Law WY, Cheung NK, Oppenheimer SJ.
    J Paediatr Child Health; 1994 Oct; 30(5):444-6. PubMed ID: 7833085
    [Abstract] [Full Text] [Related]

  • 6. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL.
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [Abstract] [Full Text] [Related]

  • 7. Calcium therapy for calcitriol-resistant rickets.
    Hochberg Z, Tiosano D, Even L.
    J Pediatr; 1992 Nov; 121(5 Pt 1):803-8. PubMed ID: 1331389
    [Abstract] [Full Text] [Related]

  • 8. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Nov; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 9. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
    Aarskog D, Aksnes L, Markestad T.
    Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
    [Abstract] [Full Text] [Related]

  • 10. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions.
    Bliziotes M, Yergey AL, Nanes MS, Muenzer J, Begley MG, Vieira NE, Kher KK, Brandi ML, Marx SJ.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):294-300. PubMed ID: 2828407
    [Abstract] [Full Text] [Related]

  • 11. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S, Garabedian M, Liberman UA, Eil C, Bourdeau A, Guillozo H, Grimberg R, Le Deunff MJ, Lieberherr M, Guimbaud P, Broyer M, Marx SJ.
    J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
    [Abstract] [Full Text] [Related]

  • 12. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 13. [Early diagnosis and early treatment of hypophosphatemic vitamin D-resistant rickets].
    Schaumberger E, Hohenauer L, Sommer R.
    Klin Padiatr; 1986 Sep; 198(1):44-8. PubMed ID: 3007858
    [Abstract] [Full Text] [Related]

  • 14. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
    Kruse K.
    J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
    [Abstract] [Full Text] [Related]

  • 15. Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.
    Takeda E, Yokota I, Kawakami I, Hashimoto T, Kuroda Y, Arase S.
    Eur J Pediatr; 1989 Oct; 149(1):54-7. PubMed ID: 2558018
    [Abstract] [Full Text] [Related]

  • 16. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK.
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [Abstract] [Full Text] [Related]

  • 17. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E, Kuroda Y, Saijo T, Naito E, Kobashi H, Yokota I, Miyao M.
    Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
    [Abstract] [Full Text] [Related]

  • 18. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH.
    Metabolism; 1990 Apr; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [Abstract] [Full Text] [Related]

  • 19. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [Abstract] [Full Text] [Related]

  • 20. Selective modulation by vitamin D of renal response to parathyroid hormone: a study in calcitriol-resistant rickets.
    Even L, Weisman Y, Goldray D, Hochberg Z.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2836-40. PubMed ID: 8768839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.